Delivery Order SPE2DB22D2206-SPE2DB25FFN59

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,736.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Modafinil 100 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,423.00 firm fixed-price delivery order is for the supply of 4,567,238,758 units of the drug Modafinil 100 mg tablet, without any set-aside designation. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,753.88 Firm Fixed Price Delivery Order contract is for the delivery of Modafinil 200 mg tablets. The contract has an ultimate completion date of August 7, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,471.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of modafinil 200mg tablets. The contract, which has a completion date of April 25, 2024, is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,922.41 firm fixed-price delivery order is for the supply of 4554407659 - Modafinil 200 mg tablets. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,134.42, is for the supply of modafinil 200 mg tablets to support military healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Modafinil 200 mg tablets. The $1,312.30 award is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award is for the delivery of modafinil 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,004.54, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price type and has an ultimate completion date of December 7, 2023. There is no set-aside designation associated with this award. Amerisourcebergen...
This federal contract award, valued at $1,901.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,563,152,256 units of the medication Modafinil 200mg tablets. The contract has an ultimate completion date of December 21, 2023 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price pricing type and a ceiling value of $1,168.81. The contract is for the delivery of 4,563,949,331 modafinil 200 mg tablets in 90-count packages, with a period of performance through March 14, 2024....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFN59
    Delivery Order

This federal contract award, valued at $5,041.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Modafinil 100 mg tablets and is classified as a Firm Fixed Price Delivery Order.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002, and this contract reflects its extensive experience and capabilities in providing critical medical commodities to various federal agencies.

Generated 5/12/25, 10:49 AM